Radcliffe Capital Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-199,350
| Closed | -$2.08M | – | 659 |
|
|
2023
Q1 | $2.08M | Buy |
199,350
+69,762
| +54% | +$728K | 0.13% | 223 |
|
|
2022
Q4 | $1.33M | Hold |
129,588
| – | – | 0.04% | 586 |
|
|
2022
Q3 | $1.3M | Buy |
129,588
+99
| +0.1% | +$995 | 0.03% | 815 |
|
|
2022
Q2 | $1.29M | Buy |
129,489
+2,220
| +2% | +$22.1K | 0.03% | 858 |
|
|
2022
Q1 | $1.27M | Buy |
127,269
+27,269
| +27% | +$272K | 0.03% | 845 |
|
|
2021
Q4 | $1M | Buy |
+100,000
| New | +$1M | 0.03% | 808 |
|